Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Contrasting whole-genome and reduced representation sequencing pipelines for population demographic inference

PROVIDER: PRJNA909334 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR22556618_1.fastq.gz	Fastqsanger.gz
	SRR22556618_2.fastq.gz	Fastqsanger.gz
	SRR22556619_1.fastq.gz	Fastqsanger.gz
	SRR22556619_2.fastq.gz	Fastqsanger.gz
	SRR22556620_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 60

Similar Datasets

Project description:Contrasting whole-genome and reduced representation sequencing pipelines for population demographic inference - high coverage genomes

| PRJNA909333 | ENA

Endonuclease enrichment TAPS for cost-effective genome-wide base-resolution DNA methylation detection

Project description:We described endonuclease enrichment TAPS (eeTAPS), which utilizes dihydrouracil (DHU)-sensitive endonuclease digestion after TAPS to enrich methylated CpG (mCpG). eeTAPS can accurately detect 87% of methylated CpGs in the mouse genome with a sequencing depth comparable to 4x whole genome sequencing. In comparison, reduced representation TAPS (rrTAPS) detected less than 4% of methylated CpGs with 2.5x sequencing depth. Our results demonstrate eeTAPS to be a new strategy for cost-effective genome-wide methylation analysis at single-CpG resolution that can fill the gap between whole-genome and reduced representation sequencing.

2021-04-01 | GSE148197 | GEO

Project description:Reduced representation genome sequencing

| PRJNA811778 | ENA

Project description:Reduced-Representation Genome Sequencing

| PRJNA777040 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

Mus musculus

Project description:Reduced representation bisulfite sequencing

| PRJNA347548 | ENA

Project description:Reduced representation sequencing optimization

| PRJNA674352 | ENA

Project description:A comparison of phylogenomic inference pipelines for low-coverage whole-genome sequencing in Formica ants

| PRJNA1193675 | ENA

Project description:Tetraena mongolica Reduced-Representation Sequencing

| PRJNA601311 | ENA

Acipenser oxyrinchus oxyrinchus

Project description:Acipenser oxyrinchus Reduced Representation Sequencing